Valuation: COMPASS Pathways plc

Market Cap 156.14Cr 135.62Cr 125.94Cr 116.15Cr 218.78Cr 15TCr 222.74Cr 1.49TCr 583.78Cr 7.4TCr 586.34Cr 573.5Cr 25TCr P/E 2026 *
-12.4x
P/E 2027 * -7.97x
Enterprise Value 113.72Cr 99Cr 92Cr 85Cr 159.35Cr 11TCr 162.24Cr 1.09TCr 425.2Cr 5.39TCr 427.07Cr 417.72Cr 18TCr EV / Sales 2026 *
-
EV / Sales 2027 * 17.8x
Free-Float
25.07%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: COMPASS Pathways plc

1 day-2.38%
1 week+2.13%
Current month-18.73%
1 month-13.47%
3 months+27.64%
6 months+73.98%
Current year+66.67%
1 week 10.59
Extreme 10.59
11.79
1 month 10.59
Extreme 10.59
14.6
Current year 4.88
Extreme 4.88
15.4
1 year 3.97
Extreme 3.97
15.4
3 years 2.25
Extreme 2.25
15.4
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 01/08/2022
Director of Finance/CFO 54 01/03/2024
Chief Tech/Sci/R&D Officer 66 01/05/2024
Director TitleAgeSince
Chairman 74 29/03/2024
Director/Board Member 69 01/04/2020
Director/Board Member 67 01/03/2021
Date Insider Type Main position Quantity % Market Cap.
26/03/26 Free

Chief Executive Officer

5,42,815 0.5658%
11/03/26 Tax

Chief Financial Officer

1,781 0.0019%
02/02/26 Tax

Chief Executive Officer

16,181 0.0169%
Change 5-day change 1-year change 3-year change Capi.($)
-2.12%+2.13%+164.37%+23.39% 156.14Cr
-1.00%+3.10%-1.22%+11.84% 4.94TCr
-2.33%+11.51%+24.83%+3.68% 3.91TCr
-2.84%-0.43%+405.52%+617.74% 4.09TCr
-2.60%-3.45%+4.49%+46.88% 3.58TCr
-1.74%+8.42%+8.85%+48.87% 3.05TCr
-2.03%-3.09% - - 1.66TCr
-1.74%-5.55%+32.95%+124.35% 1.61TCr
-1.40%-1.29%-3.29%-34.92% 1.28TCr
-0.12%+3.19%+1.78%+9.49% 1.37TCr
Average -1.83%+4.34%+70.92%+94.59% 2.56TCr
Weighted average by Cap. -1.92%+6.62%+77.88%+128.67%

Financials

2026 *2027 *
Net sales - 5.94Cr 5.16Cr 4.79Cr 4.42Cr 8.33Cr 567.35Cr 8.48Cr 57Cr 22Cr 281.77Cr 22Cr 22Cr 947.58Cr
Net income -9.82Cr -8.53Cr -7.92Cr -7.3Cr -14Cr -937.08Cr -14Cr -94Cr -37Cr -465.4Cr -37Cr -36Cr -1.57TCr -20Cr -17Cr -16Cr -15Cr -28Cr -1.89TCr -28Cr -188.85Cr -74Cr -937.69Cr -74Cr -73Cr -3.15TCr
Net Debt -42Cr -37Cr -34Cr -32Cr -59Cr -4.05TCr -61Cr -405Cr -158.57Cr -2.01TCr -159.27Cr -155.78Cr -6.76TCr -50Cr -44Cr -41Cr -38Cr -71Cr -4.81TCr -72Cr -481.56Cr -188.55Cr -2.39TCr -189.38Cr -185.23Cr -8.04TCr
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
31/26/31 $11.50 -0.65% 9,07,974
30/26/30 $11.57 +6.15% 19,68,680
29/26/29 $10.90 +0.46% 27,67,188
28/26/28 $10.85 -3.73% 26,70,643
27/26/27 $11.27 +0.09% 29,83,857
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
11.57USD
Average target price
23.75USD
Spread / Average Target
+105.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock